Jiang Xi, Zhang Xin, Zhu Dajiang
1 Cortical Architecture Imaging and Discovery Lab, Department of Computer Science, Boyd Graduate Studies Research Center, The University of Georgia , Athens, Georgia .
Brain Connect. 2014 Oct;4(8):575-86. doi: 10.1089/brain.2013.0221. Epub 2014 Jul 31.
Alzheimer's disease (AD) is the most common type of dementia (accounting for 60% to 80%) and is the fifth leading cause of death for those people who are 65 or older. By 2050, one new case of AD in United States is expected to develop every 33 sec. Unfortunately, there is no available effective treatment that can stop or slow the death of neurons that causes AD symptoms. On the other hand, it is widely believed that AD starts before development of the associated symptoms, so its prestages, including mild cognitive impairment (MCI) or even significant memory concern (SMC), have received increasing attention, not only because of their potential as a precursor of AD, but also as a possible predictor of conversion to other neurodegenerative diseases. Although these prestages have been defined clinically, accurate/efficient diagnosis is still challenging. Moreover, brain functional abnormalities behind those alterations and conversions are still unclear. In this article, by developing novel sparse representations of whole-brain resting-state functional magnetic resonance imaging signals and by using the most updated Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset, we successfully identified multiple functional components simultaneously, and which potentially represent those intrinsic functional networks involved in the resting-state activities. Interestingly, these identified functional components contain all the resting-state networks obtained from traditional independent-component analysis. Moreover, by using the features derived from those functional components, it yields high classification accuracy for both AD (94%) and MCI (92%) versus normal controls. Even for SMC we can still have 92% accuracy.
阿尔茨海默病(AD)是最常见的痴呆类型(占60%至80%),是65岁及以上人群的第五大死因。到2050年,预计美国每33秒就会出现一例新的AD病例。不幸的是,目前尚无有效的治疗方法能够阻止或减缓导致AD症状的神经元死亡。另一方面,人们普遍认为AD在相关症状出现之前就已开始,因此其前期阶段,包括轻度认知障碍(MCI)甚至显著的记忆问题(SMC),不仅因其作为AD前驱的可能性,还因其可能作为向其他神经退行性疾病转化的预测指标而受到越来越多的关注。尽管这些前期阶段已在临床上得到定义,但准确/高效的诊断仍然具有挑战性。此外,这些改变和转化背后的脑功能异常仍不清楚。在本文中,通过开发全脑静息态功能磁共振成像信号的新型稀疏表示,并使用最新的阿尔茨海默病神经影像学倡议(ADNI)数据集,我们成功地同时识别了多个功能成分,这些成分可能代表参与静息态活动的内在功能网络。有趣的是,这些识别出的功能成分包含了从传统独立成分分析中获得的所有静息态网络。此外,通过使用从这些功能成分中提取的特征,对AD(94%)和MCI(92%)与正常对照的分类准确率都很高。即使对于SMC,我们仍然可以达到92%的准确率。